Connect with us

Featured

2 Blue-Chip Tech Stocks With Big Moves in the First Half

Joe Samuel

Published

on

adbe stock price twlo stock price

As far investment sectors are concerned, the tech sector has almost always been the favorite of a majority of investors and the reasons are manifold. One of the bigger reasons is that technology is evolving very quickly. Companies which can come up with innovative solutions stand to grow quicker than stock in most other sectors.

Therefore, investors need to keep an eye on the myriad tech stocks. What will be the next big opportunity? Here is a look at two tech stocks which made moves in the first half of the year.

Twillo Stock Price Up 53%

One of the biggest tech stock movers in the first half of 2019 has been the cloud communication platform Twillo (TWLO). Twillo stock price has surged by 53% so far. However, in this regard, it is important to add that the company had been growing steadily for more than a year. Its stock performance is a reflection on the Twillo’s consistency.

Read More: How Can On Demand Delivery Boost Tech Stocks?

Despite lower business volume from one of its biggest clients, Uber, the company managed to grow revenue by 81% year on year in Q1 2019. This equated to $233 million. It should also be noted that despite key acquisitions, Twillo’s organic growth rose by 60% year on year.

Moreover, the company also raised its projections for the revenue for 2019 to a range between $1.102 billion and $1.111 billion. The previous projection was between $1.065 billion and $1.077 billion. The earnings per share projection has also been raised from $.08 to $.11 to $0.11 to $.13.

Adobe Stock Price Up 30%

Another big-ticket tech stock moving in the first half of 2019 is Adobe (ADBE). Adobe stock price went up by as much as 30% during the period. Two back to back record breaking quarterly reports propelled the software company’s stock.

Additionally, it’s believed that its cloud-based subscription products also played a big role in the surge. During the previous quarter, Adobe’s revenues grew 25% year on year to hit $2.744 billion. The adjusted profits came in at $900 million, which reflected earnings per share of $1.83.

The performance overshadowed the company’s own projections of earnings per share of $1.77. Recurring revenues contributed 91% and although the company has not provided its guidance for the years, experts believe that its streak is going to continue.


Like This Article? Check Out A Special Report: On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market

Continue Reading
Click to comment

Biotechnology

3 Small-Cap Biotech Stocks To Watch In Coming Weeks

Joe Samuel

Published

on

stock market today

Biotech has been one of the hottest sectors for investors for as long as it has existed and the reasons are self-evident. It is a sector that uses cutting edge technology and comes up with treatments for a wide range of diseases.

Moreover, the fact that biotech companies often improve on existing treatments, makes them a far more attractive target for a range of investors. Here is a look at three biotech stocks to watch during the last few weeks of the quarter.

PharmaCyte Biotech (PMCB)

There has been no lack of attention on biotech penny stocks this year.  At the beginning of August, one small biotech stock broke to highs of over $10 from a starting price below $2 a share after releasing news. PharmaCyte Biotech (PMCB) focuses on ways to effectively deliver treatments to patients with diseases ranging from cancer to diabetes. 

The company’s proprietary cellulose-based live-cell encapsulation technology known as “Cell-in-a-Box®is the platform that the company uses to develop its therapy delivery methods.  For most of the quarter, shares of PMCB stock have traded between $0.033 and $0.04 with volume recently surging.

On September 19, PharmaCyte saw more than 6 million shares trade; well above its daily average. Most of the attention surrounding the company has been on two things. First, its progress with Cell-In-A-Box and the application for Pancreatic cancer has continued to progress. The company brought on Dr. Manuel Hidalgo, has confirmed that he will be Principal Investigator (PI) for PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer (LAPC) now that he is at Weill Cornell Medical Center.

What To Watch For

This week PharmaCyte (PMCB) will host a call designed to update all shareholders and the investment community simultaneously of material developments. The call will cover PharmaCyte’s preparations for submission of its Investigational New Drug application (IND) to the U.S. FDA to treat locally advanced, inoperable pancreatic cancer. It will also cover developments related to PharmaCyte’s product pipeline. PharmaCyte has been working on these and will discuss things not yet reported in a press release.

Catalyst Pharmaceuticals (CPRX)

The first one to watch is Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). It is a small-cap stock engaged in developing medicines for rare diseases. Catalyst managed to get an approval for one of its products from the FDA earlier this year.

Since the approval of the Lambert-Eaton myasthenic syndrome (LEMS treating medicine Firdapse, Catalyst stock went on a massive rally from January to April. The approval of a rival drug halted the rally. Only after a civil suit from Catalyst did the stock stabilize somewhat.

Last week, Catalyst stock received a fresh boost after the company announced that it was going to make a secondary offering. However, the company decided to pull the offering the very next day and that affected the stock price once again.

What To Watch For

Analysts believe that pulling the secondary offering was the right long term decisions and this stock could be heading for another rally soon.

Eyepoint Pharmaceuticals (EYPT)

The biotech stock that could prove to be a major winner in the biotech sector this month is that of Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT). There are two factors at play. The company revenues are going to rise significantly in the coming years due to the commercial launch of two medicines.

The first one is Yutiq, which is meant for the treatment of chronic non-infectious uveitis and the other one is Dexycu, which is meant for postoperative ocular inflammation.

What To Watch For

The company is currently trading at only double that of its future revenue and that is a very attractive multiple. EYPT stock has caught the attention of analysts on Wall Street. Guggenheim has set a 12-month target price of $4, which reflects 116% gains during the period.

stock market news today
Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 8/12/2019 – 9/12/2019. We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer

Continue Reading

Featured

Stock Price Newsletter – September 20, 2019

Joe Samuel

Published

on

defense stocks to watch

Microsoft (MSFT) Stock Price Jumps On Increased Dividend and Buyback Announcement

On Wednesday Microsoft Corporation (NASDAQ: MSFT) shares gained 1% in extended trading after the company announced that it was raising its quarterly dividend by $0.05. But there’s more to this story than meets the eye.

Click To Read More


Multi-Billion Dollar Markets Are Ready For A Shake-Up; 1 Biotech Stock Could Hold The Key

There’s no denying that biotechnology is one of the hottest markets in the world. Right now a multi-billion-dollar segment is ready for a shakeup and one biotech stock could hold the secret to doing just that!

Read More


Top 4 Penny Stocks To Watch Right Now

Penny stocks are some of the most active and volatile types of stocks in the stock market today. But what everyone knows about these is that they can break out in a big way. That’s why so many continue to look for the best penny stocks to buy.

See For Yourself

Continue Reading

Featured

Microsoft (MSFT) Stock Price Jumps On Increased Dividend and Buyback Announcement

Joe Samuel

Published

on

On Wednesday Microsoft Corporation (NASDAQ: MSFT) shares gained 1% in extended trading after the company announced that it was raising its quarterly dividend by $0.05.

Share Repurchase Program

The company has also authorized a $40 billion stock buyback. Under the leadership of CEO Satya Nadella, the company has been buying back its shares. In the fiscal year ended June 30, Microsoft bought back it’s a stock worth around $19.54 billion. The year before stock buybacks were around $10.72 billion. In the last five years under the tenure of Nadella, the company has seen it’s stock almost quadruple and exceed a trillion-dollar market cap.

The company has aggressively been repurchasing its stock and at the current rate, they are likely to use all the $40 billion in the latest repurchase program within two years. The new share repurchase program does not have an expiration period but the company could choose to terminate it any time.

Growing Dividends

The company is increasing its dividends by 5 cents barely a year after increased them. The board of directors approved a $0.51 quarterly dividend which reflects an 11% increase over the quarter before. This translates to $2.04 annually. Microsoft has been paying dividends to stockholders since 2003 and it has been pumping up its quarterly dividend each year.

Microsoft has indicated that it will pay shareholders of record on November 21 a dividend of $0.51 on December 12. The 11% increase is an improvement from last year’s dividend increase of 9.5%. The increase is slightly more than the company’s average dividend growth percentage of around 10.4%.

The share repurchase program and dividend increase are a no brainer for Microsoft. In 2019 the company brought around $38.3 billion in free cash flow of which $13.8 billion was given to shareholders in the form of dividends. The company returned around $33 billion to shareholders this is inclusive of the cash spent on stock repurchases.

Considering how trivial the company’s dividends are relative to its free cash flow, it appears like Microsoft will keep increasing its dividends each year.

A Clear Focus On Groundbreaking Technology

Global spending on security solutions is projected to reach $7.4 billion in 2019 and increase to over $11.3 billion by 2025 with a CAGR of 8.2%.  The urban Security explosives and Weapons Detection market is slated to grow to nearly $7.5 billion by 2025 and is forecast to see consistent growth for the next several years [2].

What does this mean? Well, for investors it could signal big opportunities but with so many large companies targeting surveillance systems and weapon detection devices as a “go-to,” is there anything that could truly disrupt this market?

In short, yes

Liberty Defense (SCAN.V) (LDDFF) Is Positioning To Change The Face Of Threat Detection For Good

The truth of the matter is that mass shootings now happen more than once a day in the US and as we’ve come to find, there’s no real way to stop these attacks after an attacker enters a space. This is where the real opportunity is: stopping an attack before someone even enters a vulnerable space.

Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) plans to do that using HEXWAVE, a next-generation high-tech security scanning system that will use advanced, low-power radar, 3D-imaging, and Artificial Intelligence (AI) to screen people at public gatherings such as sports games, unobtrusively.

Liberty Defense (SCAN.V) (LDDFF) Is Positioning To Change The Face Of Threat Detection For Good

The truth of the matter is that mass shootings now happen more than once a day in the US and as we’ve come to find, there’s no real way to stop these attacks after an attacker enters a space. This is where the real opportunity is: stopping an attack before someone even enters a vulnerable space.

Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) plans to do that using HEXWAVE, a next-generation high-tech security scanning system that will use advanced, low-power radar, 3D-imaging, and Artificial Intelligence (AI) to screen people at public gatherings such as sports games, unobtrusively.

Liberty Defense WSJ

The advanced attack prevention system can detect if someone is armed before they enter a building using radar energy and Artificial Intelligence (AI) to detect weapons and explosives in real-time. You may be thinking that the processes and screening technology that you see in airports can achieve the same thing in our communities.  

Urban Threat Detection

But we’re talking about urban detection; where high people traffic flow and attempts to provide airport-like screening processes can be extremely disruptive to business activity because of security entry delays. 

As important to providing a higher rate of threat screening is that there also needs to be a way to detect other potential mass attack weapons including explosives, pyrotechnics and other non-metallic threats.

Utilizing a new disruptive technology under an exclusive global license from MIT (Massachusetts Institute of Technology), Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) is developing HEXWAVE.

Liberty Defense WSJ

The advanced attack prevention system can detect if someone is armed before they enter a building using radar energy and Artificial Intelligence (AI) to detect weapons and explosives in real-time. You may be thinking that the processes and screening technology that you see in airports can achieve the same thing in our communities.  But we’re talking about urban detection; where high people traffic flow and attempts to provide airport-like screening processes can be extremely disruptive to business activity because of security entry delays. 

As important to providing a higher rate of threat screening is that there also needs to be a way to detect other potential mass attack weapons including explosives, pyrotechnics and other non-metallic threats.

Utilizing a new disruptive technology under an exclusive global license from MIT (Massachusetts Institute of Technology), Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) is developing HEXWAVE.

Click Here To Learn More About Liberty Defense and its HEXWAVE

defense stocks weapons detection
Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Liberty Defense Holdings Inc. Midam was hired for a period from 06/1/2019 – 9/30/2019 to publicly disseminate information about Liberty Defense Holdings Inc. including on the Website and other media including Facebook and Twitter. We were paid $250,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of Liberty Defense Holdings Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. For previous compensation see our FULL DISCLAIMER HERE

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com